|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 96.12 USD | +0.66% |
|
+6.40% | +13.31% |
| 03-10 | Tranche Update on Interparfums, Inc.'s Equity Buyback Plan announced on May 8, 2023. | CI |
| 03-04 | Berenberg Raises Price Target on Interparfums to $113 From $107, Keeps Buy Rating | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 9.24 | 10.29 | 11.73 | 12.53 | 11.28 | |||||
Return on Total Capital | 11.22 | 13.15 | 15.09 | 15.7 | 13.81 | |||||
Return On Equity % | 15.27 | 19.79 | 22.35 | 22.17 | 20.34 | |||||
Return on Common Equity | 15.78 | 20.35 | 23.2 | 22.76 | 20.72 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 55.47 | 55.9 | 55.8 | 55.74 | 59.13 | |||||
SG&A Margin | 38.37 | 37.3 | 36.72 | 36.54 | 40.97 | |||||
EBITDA Margin % | 18.28 | 19.96 | 20.39 | 20.87 | 19.86 | |||||
EBITA Margin % | 17.78 | 19.22 | 19.65 | 20.13 | 19.13 | |||||
EBIT Margin % | 17.11 | 18.59 | 19.08 | 19.2 | 18.16 | |||||
Income From Continuing Operations Margin % | 12.51 | 13.9 | 14.25 | 14.01 | 13.98 | |||||
Net Income Margin % | 9.94 | 11.13 | 11.59 | 11.32 | 11.31 | |||||
Net Avail. For Common Margin % | 9.94 | 11.13 | 11.59 | 11.32 | 11.31 | |||||
Normalized Net Income Margin | 8.33 | 8.85 | 9.17 | 9.03 | 8.4 | |||||
Levered Free Cash Flow Margin | -4.16 | -4.14 | -2.75 | 9.61 | 6.67 | |||||
Unlevered Free Cash Flow Margin | -3.96 | -3.93 | -2.22 | 9.95 | 6.97 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.86 | 0.89 | 0.98 | 1.04 | 0.99 | |||||
Fixed Assets Turnover | 7.74 | 5.75 | 6.71 | 7.72 | 7.7 | |||||
Receivables Turnover (Average Receivables) | 6.21 | 6.09 | 5.92 | 5.57 | 5 | |||||
Inventory Turnover (Average Inventory) | 2.19 | 1.96 | 1.76 | 1.73 | 1.68 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.9 | 2.29 | 2.58 | 2.75 | 2.99 | |||||
Quick Ratio | 2 | 1.4 | 1.36 | 1.56 | 1.85 | |||||
Operating Cash Flow to Current Liabilities | 0.49 | 0.33 | 0.33 | 0.56 | 0.62 | |||||
Days Sales Outstanding (Average Receivables) | 58.79 | 59.93 | 61.61 | 65.77 | 72.99 | |||||
Days Outstanding Inventory (Average Inventory) | 166.71 | 186.18 | 207.4 | 211.75 | 216.97 | |||||
Average Days Payable Outstanding | 49.7 | 54.52 | 51.05 | 53.65 | 52.24 | |||||
Cash Conversion Cycle (Average Days) | 175.81 | 191.6 | 217.96 | 223.87 | 237.72 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 24.93 | 26.6 | 21.56 | 20.39 | 18.81 | |||||
Total Debt / Total Capital | 19.95 | 21.01 | 17.74 | 16.94 | 15.84 | |||||
LT Debt/Equity | 21.96 | 22.31 | 17.08 | 14.45 | 12.43 | |||||
Long-Term Debt / Total Capital | 17.58 | 17.62 | 14.05 | 12 | 10.46 | |||||
Total Liabilities / Total Assets | 35.54 | 39.77 | 34.85 | 33.21 | 30.36 | |||||
EBIT / Interest Expense | 53.25 | 56.14 | 22.34 | 35.63 | 37.3 | |||||
EBITDA / Interest Expense | 59.8 | 61.81 | 24.39 | 39.57 | 41.77 | |||||
(EBITDA - Capex) / Interest Expense | 9.8 | 52.43 | 23.82 | 38.97 | 38.4 | |||||
Total Debt / EBITDA | 1.09 | 0.94 | 0.7 | 0.62 | 0.69 | |||||
Net Debt / EBITDA | -0.8 | -0.21 | 0.02 | -0.14 | -0.29 | |||||
Total Debt / (EBITDA - Capex) | 6.65 | 1.11 | 0.72 | 0.63 | 0.75 | |||||
Net Debt / (EBITDA - Capex) | -4.9 | -0.24 | 0.02 | -0.15 | -0.32 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 63.17 | 23.55 | 21.26 | 10.22 | 2.49 | |||||
Gross Profit, 1 Yr. Growth % | 68.46 | 24.47 | 21.05 | 10.1 | 1.04 | |||||
EBITDA, 1 Yr. Growth % | 103.09 | 34.9 | 23.92 | 12.82 | -2.49 | |||||
EBITA, 1 Yr. Growth % | 107.4 | 33.59 | 23.95 | 12.95 | -2.63 | |||||
EBIT, 1 Yr. Growth % | 114.66 | 34.3 | 24.41 | 10.91 | -3.04 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 120.19 | 37.27 | 24.32 | 8.34 | 2.32 | |||||
Net Income, 1 Yr. Growth % | 128.71 | 38.36 | 26.22 | 7.67 | 2.45 | |||||
Normalized Net Income, 1 Yr. Growth % | 131.9 | 31.21 | 25.74 | 8.52 | -4.65 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 127.27 | 37.45 | 25.66 | 7.79 | 2.34 | |||||
Accounts Receivable, 1 Yr. Growth % | 28.39 | 24.05 | 25.13 | 11.11 | 16.72 | |||||
Inventory, 1 Yr. Growth % | 25.24 | 45.78 | 28.23 | 0.02 | -5.52 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 313.14 | 6.34 | 1.62 | -9.84 | 16.74 | |||||
Total Assets, 1 Yr. Growth % | 28.67 | 14.25 | 4.65 | 3.06 | 12.33 | |||||
Tangible Book Value, 1 Yr. Growth % | 11.23 | -8.93 | 23.66 | 14.73 | 20.14 | |||||
Common Equity, 1 Yr. Growth % | 6.73 | 7.84 | 13.39 | 6.5 | 18.24 | |||||
Cash From Operations, 1 Yr. Growth % | 84 | -3.71 | 44.83 | 77.4 | 14.53 | |||||
Capital Expenditures, 1 Yr. Growth % | 1.18K | -76.11 | -80.85 | -26.68 | 415.06 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -231.26 | 22.99 | -1.04K | -484.59 | -22.46 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -219.64 | 22.77 | -578.17 | -593.73 | -21.91 | |||||
Dividend Per Share, 1 Yr. Growth % | 203.03 | 100 | 25 | 20 | 6.67 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 11.02 | 41.99 | 22.4 | 15.61 | 6.28 | |||||
Gross Profit, 2 Yr. CAGR % | 11.43 | 44.82 | 22.75 | 15.44 | 5.71 | |||||
EBITDA, 2 Yr. CAGR % | 19.03 | 65.52 | 29.29 | 18.24 | 4.89 | |||||
EBITA, 2 Yr. CAGR % | 19.37 | 66.45 | 28.68 | 18.32 | 4.87 | |||||
EBIT, 2 Yr. CAGR % | 19.86 | 69.8 | 29.26 | 17.47 | 3.7 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 20.27 | 73.86 | 30.64 | 16.06 | 5.28 | |||||
Net Income, 2 Yr. CAGR % | 20.45 | 77.89 | 32.15 | 16.58 | 5.03 | |||||
Normalized Net Income, 2 Yr. CAGR % | 21.18 | 74.43 | 28.44 | 16.81 | 1.72 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 20.31 | 76.75 | 31.43 | 16.38 | 5.03 | |||||
Accounts Receivable, 2 Yr. CAGR % | 9.43 | 26.2 | 24.59 | 17.91 | 13.88 | |||||
Inventory, 2 Yr. CAGR % | 8.87 | 35.12 | 36.73 | 13.25 | -2.79 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 115.38 | 109.6 | 3.95 | -4.28 | 2.6 | |||||
Total Assets, 2 Yr. CAGR % | 17.55 | 21.24 | 9.34 | 3.85 | 7.6 | |||||
Tangible Book Value, 2 Yr. CAGR % | 15.99 | 0.65 | 6.12 | 19.11 | 17.4 | |||||
Common Equity, 2 Yr. CAGR % | 10.55 | 7.29 | 10.58 | 9.89 | 12.22 | |||||
Cash From Operations, 2 Yr. CAGR % | 25.07 | 33.11 | -5.95 | 60.29 | 42.54 | |||||
Capital Expenditures, 2 Yr. CAGR % | 410.21 | 75.09 | -78.61 | -62.53 | 94.33 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -19.12 | 27.06 | -0.4 | 500.53 | 65.38 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -22.02 | 21.2 | -8.33 | 385.89 | 88.33 | |||||
Dividend Per Share, 2 Yr. CAGR % | -7.15 | 146.18 | 58.11 | 22.47 | 13.14 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 9.19 | 15.05 | 34.71 | 18.2 | 11.06 | |||||
Gross Profit, 3 Yr. CAGR % | 8.82 | 15.63 | 36.42 | 18.38 | 13.16 | |||||
EBITDA, 3 Yr. CAGR % | 14.98 | 24.1 | 50.3 | 23.55 | 10.88 | |||||
EBITA, 3 Yr. CAGR % | 15.4 | 23.93 | 50.87 | 23.21 | 10.88 | |||||
EBIT, 3 Yr. CAGR % | 16.67 | 24.49 | 53.08 | 22.83 | 10.19 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 16.43 | 25.69 | 55.47 | 22.74 | 11.28 | |||||
Net Income, 3 Yr. CAGR % | 17.57 | 26.15 | 58.66 | 23.43 | 11.66 | |||||
Normalized Net Income, 3 Yr. CAGR % | 18.54 | 24.43 | 56.4 | 21.43 | 9.17 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 17.16 | 25.77 | 57.75 | 23.02 | 11.5 | |||||
Accounts Receivable, 3 Yr. CAGR % | 6.11 | 14.1 | 25.84 | 19.92 | 17.51 | |||||
Inventory, 3 Yr. CAGR % | 7.13 | 20 | 32.79 | 23.2 | 6.61 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 164.99 | 70.23 | 64.66 | -0.86 | 2.27 | |||||
Total Assets, 3 Yr. CAGR % | 12.81 | 16.44 | 15.44 | 7.21 | 6.6 | |||||
Tangible Book Value, 3 Yr. CAGR % | 13.73 | 7 | 7.8 | 8.92 | 19.45 | |||||
Common Equity, 3 Yr. CAGR % | 8.51 | 9.64 | 9.29 | 9.21 | 12.61 | |||||
Cash From Operations, 3 Yr. CAGR % | 23.79 | 14.63 | 17.63 | 16.2 | 43.3 | |||||
Capital Expenditures, 3 Yr. CAGR % | 229.31 | 83.91 | -16.26 | -67.75 | -10.24 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -4.56 | -6.99 | 9.2 | 56.26 | 194.9 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -7.29 | -9.29 | 0.18 | 60.69 | 156.93 | |||||
Dividend Per Share, 3 Yr. CAGR % | 3.38 | 19.91 | 96.4 | 44.22 | 16.96 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 11.04 | 12.94 | 14.3 | 15.27 | 22.53 | |||||
Gross Profit, 5 Yr. CAGR % | 11.07 | 12.53 | 14.19 | 15.55 | 24.89 | |||||
EBITDA, 5 Yr. CAGR % | 15.75 | 19.09 | 20.5 | 21.72 | 30.15 | |||||
EBITA, 5 Yr. CAGR % | 16.27 | 19.21 | 20.54 | 21.66 | 30.45 | |||||
EBIT, 5 Yr. CAGR % | 17.32 | 20.13 | 21.55 | 21.63 | 30.99 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 20.53 | 22.28 | 21.92 | 21.74 | 33.03 | |||||
Net Income, 5 Yr. CAGR % | 21.27 | 23.8 | 23.2 | 22.23 | 34.53 | |||||
Normalized Net Income, 5 Yr. CAGR % | 17.56 | 21.4 | 22.4 | 21.33 | 31.68 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 20.78 | 23.23 | 22.67 | 21.93 | 34.06 | |||||
Accounts Receivable, 5 Yr. CAGR % | 8.73 | 10.35 | 13.15 | 15.61 | 20.91 | |||||
Inventory, 5 Yr. CAGR % | 15.45 | 16.17 | 18.11 | 17.25 | 17.21 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 78.6 | 79.91 | 82.25 | 35.21 | 36.27 | |||||
Total Assets, 5 Yr. CAGR % | 10.91 | 10.97 | 11.41 | 11.23 | 12.23 | |||||
Tangible Book Value, 5 Yr. CAGR % | 13.92 | 6.96 | 10.62 | 11.69 | 11.54 | |||||
Common Equity, 5 Yr. CAGR % | 9.08 | 7.32 | 9.34 | 9.74 | 10.45 | |||||
Cash From Operations, 5 Yr. CAGR % | 16.99 | 26.26 | 10.9 | 19.67 | 27.02 | |||||
Capital Expenditures, 5 Yr. CAGR % | 96.87 | 62.03 | 10.32 | -2.67 | 17.26 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -6.29 | 8.47 | -2.92 | 20.07 | 28.92 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -7.74 | 6.49 | -7.71 | 20.33 | 28.96 | |||||
Dividend Per Share, 5 Yr. CAGR % | 10.03 | 22.67 | 22.53 | 20.93 | 57.52 |
- Stock Market
- Equities
- IPAR Stock
- Financials Interparfums, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















